HM
LEGN icon

HealthCor Management’s Legend Biotech LEGN Stock Holding History

HealthCor Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-75,000
Closed -$3.19M – 51
2020
Q2 		$3.19M Buy
+75,000
New +$2.93M 0.13% 45

Other funds holding LEGN

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HealthCor Management's LEGN Position: Q3 2020 in Review

HealthCor Management sold out of Legend Biotech (LEGN) in Q3 2020, closing a stake of 75,000 shares — an estimated $3.19M sold.

HealthCor Management first reported a position in LEGN in Q2 2020 and held it in 1 quarter. The position peaked at $3.19M in Q2 2020. 50 funds tracked by Wall St. Rank hold LEGN as of Q3 2020.

  • HealthCor Management reported no remaining Legend Biotech position as of Q3 2020 after selling out during the quarter.
  • HealthCor Management sold 75,000 Legend Biotech shares in Q3 2020, an estimated $3.19M.
  • HealthCor Management first reported a position in Legend Biotech in Q2 2020 and held it in 1 quarter.
  • HealthCor Management's Legend Biotech position peaked at $3.19M in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2020.

Based on HealthCor Management's 13F filing for Q3 2020, filed 16 Nov 2020.